McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
via Google News
The Latest on: Drug discovery
- Anti-Diarrhea Drug May Treat Main Symptoms of Autismon September 18, 2022 at 7:10 am
Loperamide, a common anti-diarrhea drug, may treat social symptoms related to autism. The corresponding study was published in Frontiers in Pharmacology.&n | Drug Discovery And Development ...
- A Gold-Coated Sensor Could Reshape Cancer Drug Discoveryon September 16, 2022 at 3:01 pm
Stanford University engineers designed a sensor that can wrap around a tumor and measure its growth or shrinkage in real time—a step forward that will help researchers evaluate cancer drugs and one ...
- The future of AI drug discovery & development in immunology and GPCR researchon September 16, 2022 at 12:00 am
Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares.
- The AI-based drug discovery market is projected to grow at an annualized rate of 25%, during the period 2022-2035, claims Roots Analysison September 15, 2022 at 7:14 am
Stakeholders in the pharmaceutical industry are currently exploring the implementation of artificial intelligence (AI) based tools to expedite drug discovery timelines, minimize attrition rates of ...
- Cancer Immunotherapy Drug Discovery Outsourcing Market Size to Reach USD 2562.58 Million by 2030, Says The Brainy Insightson September 14, 2022 at 4:34 am
The rise in government healthcare expenditure to make treatments accessible and affordable for the citizenry will also aid in the growth of the cancer immunotherapy drug discovery outsourcing market.
- The Netflix of Digital Biology? Recursion Is Reimagining Drug Discoveryon September 13, 2022 at 10:30 am
By applying a proprietary OS to drug discovery, Recursion is turning drug discovery from sequential testing into a search problem.
- PhoreMost in drug target discovery collaboration with Rocheon September 13, 2022 at 6:48 am
UK-based biopharmaceutical company, PhoreMost, is to deploy its in-house expertise and next-generation phenotypic screening platform, SITESEEKER, toward disease-relevant pathways nominated by Roche.
- Drug Discovery Outsourcing Market Worth $6.3 Billion by 2030: Grand View Research, Inc.on September 12, 2022 at 7:00 am
The global drug discovery outsourcing market size is expected to reach USD 6.3 billion by 2030 at a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. The ...
- Drug Discovery Services Market Growth Status, Share, Size, Trends and Forecast 2028on September 9, 2022 at 1:16 am
The Global Drug Discovery Services Market is poised to value USD 41034 million by 2028 end at a CAGR of 14.3% during ...
- Sanofi strikes $20m AI drug discovery deal with Atomwiseon September 7, 2022 at 6:10 am
The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.
via Bing News